The CDC has issued its updated 2026 adult immunization schedule, adding refined RSV vaccine eligibility, annual COVID-19 boosters, and clarified pneumococcal options. The changes aim to simplify ...
—Among adults, coverage and preventable burdens were lowest for pneumococcal conjugate vaccine (PCV) 15 and highest for PCV31, with PCV21 preventing notable burdens of both acute respiratory ...
The American Academy of Pediatrics released its recommendations for childhood vaccines on Monday, breaking significantly with the guidance released by the Centers for Disease Control and Prevention ...
See more on Vaxcyte's (PCVX) and VAX-31’s broad pneumococcal vaccine pipeline, strong cash runway, and key 2026–2027 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results